ホーム › 大腸癌 › ネブラスカ州

ネブラスカ州における大腸癌の臨床試験

ネブラスカ州内の拠点で、大腸癌に関する22件の研究が参加者を募集しています。

ネブラスカ州内の都市

公式研究テキスト（英語）

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

Nebraska Medicine-Bellevue, Bellevue
Nebraska Medicine-Village Pointe, Omaha
University of Nebraska Medical Center, Omaha

被験者募集中第2相

18歳以上 · 全性別 · 2026/10/02更新 · NCT05673148

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

CHI Health Saint Francis, Grand Island
CHI Health Good Samaritan, Kearney
Alegent Health Immanuel Medical Center, Omaha
他2件

被験者募集中観察研究健康なボランティア歓迎

40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069

Family Communications After Genetic Testing

CHI Health Saint Francis, Grand Island
CHI Health Good Samaritan, Kearney
Alegent Health Immanuel Medical Center, Omaha
他2件

被験者募集中健康なボランティア歓迎

18歳以上 · 全性別 · 2026/10/02更新 · NCT07143487

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Exelixis Clinical Site #2, Omaha

被験者募集中第1相

18歳以上 · 全性別 · 2026/10/01更新 · NCT05176483

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

Nebraska Cancer Specialists, Omaha
XCancer, Omaha

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/10/01更新 · NCT07189871

A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

Nebraska Cancer Specialists - Omaha - Wright Street /ID# 271646, Omaha

被験者募集中第2相

18歳以上 · 全性別 · 2026/09/28更新 · NCT06820463

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Cancer Partners of Nebraska, Lincoln

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/28更新 · NCT07222800

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

Nebraska Cancer Specialists, Omaha

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/25更新 · NCT06750094

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

Nebraska Cancer Specialists Midwest Cancer Center, Omaha

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/25更新 · NCT06662786

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

University Of Nebraska Medical Center, Omaha

被験者募集中第2/3相

18歳以上 · 全性別 · 2026/09/23更新 · NCT07221357

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

Nebraska Cancer Specialists, Omaha
University of Nebraska Medical Center, Omaha

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/09/22更新 · NCT06445062

Zanzalintinib Alone or in Combination With Pembrolizumab and Berahyaluronidase Alfa in Participants With Colorectal Cancer With Molecular Residual Disease

Oncology Hematology West, PC dba Nebraska Cancer Specialists - Grand Island, Grand Island
Oncology Hematology West, PC dba Nebraska Cancer Specialists - Regional, Grand Island
Oncology Hematology West, PC dba Nebraska Cancer Specialists - Methodist, Omaha
他3件

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/21更新 · NCT07750158